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The aim of this study was to compare stroke volume (SVI) to cardiac index (CI) guided resuscitation in a bleeding-resuscitation
experiment. Twenty six pigs were randomized and bled in both groups till baseline SVI (𝑇bsl) dropped by 50% (𝑇0), followed by
resuscitation with crystalloid solution until initial SVI or CI was reached (𝑇
4
). Similar amount of blood was shed but animals
received significantly less fluid in the CI-group as in the SVI-group: median = 900 (interquartile range: 850–1780) versus 1965
(1584–2165) mL, 𝑝 = 0.02, respectively. In the SVI-group all variables returned to their baseline values, but in the CI-group animals
remained underresuscitated as indicated by SVI, heart rate (HR) and stroke volume variation (SVV), and central venous oxygen
saturation (ScvO2) at 𝑇4 as compared to 𝑇bsl: SVI = 23.8 ± 5.9 versus 31.4 ± 4.7mL, HR: 117 ± 35 versus 89 ± 11/min SVV: 17.4 ± 7.6
versus 11.5 ± 5.3%, and ScvO2: 64.1 ± 11.6 versus 79.2 ± 8.1%, 𝑝 < 0.05, respectively. Our results indicate that CI-based goal-directed
resuscitationmay result in residual hypovolaemia, as bleeding caused stress induced tachycardia “normalizes” CI, without restoring
adequate SVI. As the SVI-guided approach normalized most hemodynamic variables, we recommend using SVI instead of CI as
the primary goal of resuscitation during acute bleeding.
1. Introduction
Acute bleeding due to trauma, surgery, or gastrointestinal dis-
orders is a life threatening condition requiring immediate and
adequate interventions, of which intravenous fluid therapy is
regarded as the first step of resuscitation. Although lifesaving
at the time, inadequate fluid resuscitation can lead to hypo-
or hyper-perfusion causing the development of multiorgan
disorders at a later stage, which then severely affects the out-
come of these patients [1, 2]. Therefore, the use of early and
efficient therapeutic strategies able to detect and to treat the
imbalance between oxygen delivery and consumption is of
particular importance in critically ill patients, which has been
recognized for decades [3].
Traditional endpoints of resuscitation, such as heart rate,
blood pressure, mental status, and urine output can be useful
in the initial identification of inadequate perfusion but are
limited in their ability to identify ongoing, compensated
shock [4].More detailed assessment of global macrohemody-
namic indices such as cardiac output and derived variables,
measures of oxygen debt, may be necessary to guide treat-
ment [5, 6].
Cardiac output calculated from thermodilution or pulse
contour analysis is the most often used end-point during
goal-directed therapy [7, 8]. However, there is no consensus
on the best or universally accepted parameter as resuscitation
target. In a recent animal experiment we described changes
in central venous oxygen saturation (ScvO2) and venous-to-
arterial carbon dioxide gap (dCO
2
) during an experimental
stroke volume index- (SVI-) guided bleeding and fluid resus-
citationmodel on porcine.We found that dCO
2
may be a use-
ful hemodynamic endpoint of resuscitation, while ScvO2 is
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not strictly a hemodynamic parameter, but rather an indica-
tor of the balance between oxygen delivery and consumption
[9]. However, we also noticed that normalizing stroke volume
index resulted in higher cardiac index (CI) by the end of
resuscitation as compared with baseline, possibly because of
the bleeding-induced tachycardia. Hence we hypothesized
that normalizing cardiac output only may mask ongoing
hypovolemia due to increased heart rate caused by sympa-
thetic response and may result in inadequate fluid resusci-
tation. Therefore, the objective of the current study was to
compare SVI as primary target of fluid resuscitation to CI-
based treatment in a bleeding-resuscitation animal model.
2. Materials and Methods
The experiments were performed on the EU Directive
2010/63/EU on the protection of animals used for exper-
imental and other scientific purposes and carried out in
strict adherence to the NIH guidelines for the use of exper-
imental animals. The study was approved by the National
Scientific Ethical Committee on Animal Experimentation
(National Competent Authority), with the license number
V./142/2013.
2.1. Animals and Instrumentation. Vietnamese mini-pigs
(𝑛 = 27) underwent a 12-hour fasting preoperatively but with
free access towater. Anesthesia was induced by intramuscular
injection of a mixture of ketamine (20mg/kg) and xylazine
(2mg/kg) and maintained with a continuous intravenous
infusion of propofol (6mg/kg/hr iv.), while analgesia was
performedwith nalbuphine (0.1mg/kg).The animals’ trachea
was intubated and the lungs were ventilated mechanically
with Dra¨ger Evita XL (Dra¨ger, Lu¨beck, Germany). The tidal
volume was set at 10mL/kg, and the respiratory rate was
adjusted to maintain the end-tidal carbon dioxide and partial
pressure of arterial carbon dioxide in the range of 35–
45mmHg. The adequacy of the depth of anesthesia was
assessed by monitoring the jaw tone. After induction of
anesthesia, the right jugular vein, the left carotid artery, and
the right femoral artery were dissected and catheterized using
aseptic technique. For invasive hemodynamic monitoring, a
transpulmonary thermodilution catheter (PiCCO, PULSION
Medical Systems SE, Munich, Germany) was placed in the
right femoral artery. Central venous catheter was inserted via
the right jugular vein and was positioned by the guidance
of intracavital ECG. During the bleeding phase blood was
drained from a sheat inserted in the left carotid artery.
Animals were kept warm (37 ± 1∘C) by an external warming
device.
2.2. HemodynamicMonitoring and Blood Gas Sampling. Car-
diac output (CO), global end-diastolic volume index (GEDI),
stroke volume (SV), cardiac function index (CFI), index of
left ventricular contractility (dPmax), SV variation (SVV),
pulse pressure variation (PPV), heart rate (HR), and mean
arterial pressure (MAP) were measured by transpulmonary
thermodilution and pulse contour analysis at baseline and at
the end of each interval. All hemodynamic parameters were
indexed for body surface area or bodyweight. Central venous
catheter was used for the injection of cold saline boluses
for the thermodilution measurements. The average of three
measurements following 10mL bolus injections of ice-cold
0.9% salinewas recorded. Central venous pressure (CVP)was
measured via central venous catheter at the same times as the
other hemodynamic variables.
For blood gas measurements the right femoral artery
served as the site for arterial blood gas sampling and the
central venous line was used for taking central venous blood
gas samples, which were analyzed by cooximetry (Cobas b
221, Roche Ltd., Basel, Switzerland) simultaneously at base-
line and at the end of each step. From these parameters the
following variables were calculated:
Delivery of oxygen (DO
2
)
= CI ∗ (Hb ∗ 1.34 ∗ SaO
2
+ 0.003 ∗ PaO
2
) ,
Oxygen consumption (VO
2
)
= CI
∗ (CaO
2
− (Hb ∗ 1.34 ∗ ScvO2 + 0.003 ∗ PcvO2)) ,
Oxygen extraction = VO2
DO
2
.
(1)
2.3. Experimental Protocol. The flowchart of the experiment
is summarized in Figure 1. After the instrumentation, animals
were allowed to rest for 30 minutes after which baseline
(𝑇bsl) hemodynamic, microcirculatory measurements, blood
gas analyses, including lactate measurements, and laboratory
testingwere performed.After thesemeasurements, bloodwas
drained until the stroke volume index dropped by 50% of
its baseline value (𝑇
0
); then measurements were repeated.
At this point the animals were randomized into two groups.
In the SVI-group the difference of the SVI
𝑇bsl
− SVI
𝑇0
was
divided into four equal target values, which was aimed to
reach in 4 steps during fluid resuscitation (𝑇
1–4) to reach the
initial SVI by 𝑇
4
. While in the CI-group the difference of the
CI
𝑇bsl
− CI
𝑇0
was divided into 4 target values and then the
animals were resuscitated in 4 steps in order to reach the
CI
𝑇bsl
by𝑇
4
. Fluid replacement was carried out with boluses of
200mL of balanced crystalloid Ringerfundin (B. Braun AG.,
Melsungen, Germany) over 10 minutes, till the target SVI or
CI value was reached. After reaching each step, 20 minutes
was allowed for equilibrium; then hemodynamic and blood
gas parameters were measured. At the end of the experiment
the animals were euthanized with sodium pentobarbital.
2.4. Data Analysis and Statistics. Data are presented as mean ±
standard deviations unless indicated otherwise. For testing
normal distribution the Kolmogorov-Smirnov test was used.
Changes in all parameters throughout the experiment were
tested by two-way repeated measures analysis of variance
(RM ANOVA) and for the post hoc test Bonferroni test was
used. For pairwise comparisons Pearson’s correlation was used.
The primary end point of the study was the normalization of
SVV, as the one of the best indicators of hypo-, normovolemia
BioMed Research International 3
Hemodynamic
measurements
Blood gas
sampling
restoration
after bleeding
Hemodynamic
measurements
Blood gas
sampling
SVI-group
Hemodynamic measurements
Blood gas sampling
CI-group
Hemodynamic measurements
Blood gas sampling
0
Bleeding
30 60
Fluid resuscitation
90 120 150 180Time(min)
Tbasl T1 T2T0 T3 T4
Target: 50%
drop of SVITbsl
10min for
Target: T1: 62,5% SVITbasl ; T2: 75% SVITbasl ; T3: 87,5% SVITbasl ; T4: 100% SVITbasl
Target: T1: 62,5% CITbasl ; T2: 75% CITbasl ; T3: 87,5% CITbasl ; T4: 100% CITbasl
After 20min ﬂuid resuscitation, 10min for equilibration
After 20min ﬂuid resuscitation, 10min for equilibration
Figure 1: Flow chart. Schematic diagram illustrating the flowchart of the experimental protocol. After baseline measurement, animals were
bled until the stroke volume index (SVI) decreased by 50% (𝑇
0
); then measurements were repeated and randomized into two group. In the
SVI-group the difference of the SVI
𝑇bsl
− SVI
𝑇0
was divided into four equal target values (𝑇
1–4), and fluid resuscitated to reach the initial SVI
by 𝑇
4
. In the CI-group the difference of the CI
𝑇bsl
− CI
𝑇0
was divided into 4 target values and then the animals were resuscitated in 4 steps in
order to reach the CI
𝑇bsl
by 𝑇
4
.
in mechanically ventilated subjects [10]. Based on the results
of our previous animal experiment [9] SVV was found to
be 12.2 ± 4.3% by the end of resuscitation. Considering that
CI-based resuscitation remains inadequate, we regarded a
clinically significant difference of 4% (i.e., 12% in the SVI-
group and 16% in the CI-group). In order the study to have
80% power to show a difference between the two groups if
𝛼 < 0.05, the required sample size is aminimumof 20 animals
(10 in each group). For statistical analysis SPSS version 20.0
for Windows (SPSS, Chicago, IL) was used and 𝑝 < 0.05 was
considered statistically significant.
3. Results
All animals survived the experiment, apart from one (CI-
group), which had sudden cardiac arrest after induction of
anesthesia for unknown reasons. Therefore, the results of 14
animals in the SVI-group and 12 animals in the CI-group
were analyzed. Demographics and fluidmanagement data are
summarized in Table 1. Animals were of similar weight in
both groups. For a 50% decrease of SVI similar blood had to
be drained in the two groups. During resuscitation animals
in the SVI-group requiredmore fluid in total, and taking into
account the volume of crystalloid required to replace a unit
of 10mL blood loss, animals in the SVI-group also received
significantly more fluid (Table 1).
3.1. Macrohemodynamics. Hemodynamic parameters were
similar at𝑇bsl and goals of 50% reduction in SVI were reached
by𝑇
0
in both groups (Table 2). In the SVI-group SVI returned
to its baseline value by 𝑇
4
and CI was significantly elevated as
compared to 𝑇bsl. In the CI-group SVI remained significantly
lower as compared to 𝑇bsl. Mean arterial pressure and heart
rate showed a similar pattern in both groups, but in the
CI-group heart rate remained significantly higher by 𝑇
4
as
compared to𝑇bsl, while it normalized in the SVI-group.Mean
arterial pressure changed significantly in each group with a
similar pattern without significant differences between the
groups. There was less change in the CVP throughout the
experiment, with a significant increase at 𝑇
3
and 𝑇
4
only in
the SVI-group. Global end-diastolic volume decreased and
then increased in both groups, but while it normalized by
𝑇
4
in the SVI-group, it remained significantly lower in the
CI-group as compared to the SVI-group and as compared
to 𝑇bsl. Stroke volume variation and PPV also followed a
similar pattern, and SVV normalized in the SVI-group but
it remained significantly elevated in the CI-group, both as
compared to 𝑇bsl and between the groups at 𝑇4. Contractility,
as indicated by dPmax values did not show any considerable
change over time or between the groups.
3.2. Measures of Oxygen Debt. Oxygen delivery followed
a similar pattern in both groups, but in the CI-group it
remained significantly lower at 𝑇
4
as compared to 𝑇bsl
(Table 3). In the SVI-group there was also a considerable drop
by𝑇
4
, although it was not significant.This can be explained by
the significant and steady decrease in the hemoglobin levels
in both groups. Oxygen consumption was more or less stable
throughout the experiment, apart from a significant increase
during the bleeding phase in both groups. Oxygen extrac-
tion changed accordingly with no major difference between
the groups. Arterial pH, oxygen partial pressure, and oxygen
saturation remained stable and within the normal range
throughout.
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Table 1: Demographics and fluid therapy.
SVI-group (𝑛 = 14) CI-group (𝑛 = 12) 𝑝
Weight (kg) 29.00 ± 5.36 27.54 ± 5.46 0.606
BSA (m2) 0.98 ± 0.09 0.93 ± 0.91 0.390
Shed blood (mL) 485 ± 91 479 ± 101 0.859
Shed blood (mL/m2) 492 ± 59 508 ± 101 0.719
Total amount of the replaced fluid (mL) 1965 [1584–2165] 900 [850–1780] 0.020∗
Required fluid (mL)/unit blood loss (10mL) 40 ± 12 25 ± 12 0.027∗
SVI (stroke volume index), SVI-group; CI (cardiac index), CI-group. Data are presented as mean ± standard deviation or median [interquartile range] as
appropriate. ∗𝑝 < 0.05.
Table 2: Hemodynamic parameters during hemorrhage and fluid resuscitation.
Group 𝑇bsl 𝑇0 𝑇1 𝑇2 𝑇3 𝑇4
Stroke volume index (mL/m2) SVI 27.5 ± 5.4 13.8 ± 2.6
∗ 16.5 ± 2.8∗ 19.5 ± 3.7∗# 23.6 ± 5.1# 28.0 ± 5.0#
CI 31.4 ± 4.7 14.4 ± 9.0∗ 18.1 ± 3.6∗ 19.2 ± 3.6∗ 23.2 ± 1.3∗# 23.8 ± 5.9∗#@
Cardiac index (L/min/m2) SVI 2.6 ± 0.3 1.8 ± 0.3
∗ 2.1 ± 0.4∗ 2.4 ± 0.3# 2.7 ± 0.4# 2.9 ± 0.4∗#
CI 2.8 ± 0.3 1.7 ± 0.5∗ 2.1 ± 0.3∗ 2.4 ± 0.2# 2.6 ± 0.4# 2.7 ± 0.3#
Mean arterial pressure (mmHg) SVI 116 ± 17 72 ± 17
∗ 75 ± 19∗ 78 ± 18∗ 86 ± 17∗ 92 ± 16∗#
CI 124 ± 12 75 ± 22∗ 77 ± 18∗ 80 ± 81∗ 86 ± 22∗ 96 ± 20∗#
Heart rate (beats/min) SVI 95 ± 13 133 ± 22
∗ 130 ± 29∗ 121 ± 21∗ 111 ± 18# 101 ± 12#
CI 89 ± 11 139 ± 37∗ 131 ± 13∗ 127 ± 28∗ 121 ± 24∗ 117 ± 35∗
Central venous pressure (mmHg) SVI 5.9 ± 1.0 4.8 ± 0.7 5.5 ± 1.9 5.6 ± 1.4 6.1 ± 1.2
# 6.2 ± 1.3#
CI 6.0 ± 0.6 4.7 ± 0.8 5.3 ± 0.6 5.6 ± 0.5 6.2 ± 1.5 6.5 ± 0.7
Global end-diastolic volume (mL/m2) SVI 308 ± 56 237 ± 61
∗ 243 ± 59∗ 251 ± 46∗ 282 ± 58# 298 ± 53#
CI 312 ± 33 191 ± 56∗@ 204 ± 32∗ 211 ± 27∗ 243 ± 32∗# 247 ± 32∗#@
Stroke volume variation (%) SVI 14.7 ± 4.7 22.1 ± 5.5
∗ 22.2 ± 4.9∗ 18.5 ± 4.6 16.7 ± 5.2# 12.1 ± 3.6#
CI 11.5 ± 5.3 18.6 ± 5.2∗ 18.7 ± 3.7∗ 21.3 ± 4.8 19.3 ± 4.1∗ 17.4 ± 7.6∗@
Pulse pressure variation (%) SVI 14.2 ± 5.3 24.6 ± 6.9
∗ 23.3 ± 6.7∗ 19.0 ± 5.8# 16.7 ± 5.2# 13.1 ± 4.1#
CI 12.2 ± 3.1 25.2 ± 6.7∗ 22.8 ± 5.4∗ 19.8 ± 4.5# 17.4 ± 5.8# 16.3 ± 6.7#
Systemic vascular resistance index (dyn×s/cm5/m2) SVI 3261 ± 942 3100 ± 873 2677 ± 734 2442 ± 698
∗# 2410 ± 466∗# 2336 ± 475∗#
CI 3507 ± 597 3191 ± 709 2767 ± 630∗ 2652 ± 240∗ 2508 ± 565∗ 2481 ± 495∗#
EVLWI (mL/kg) SVI 10.1 ± 1.9 10.0 ± 2.2 9.9 ± 1.9 9.0 ± 1.5 9.3 ± 1.6 9.8 ± 1.7
CI 7.4 ± 1.2@ 7.2 ± 0.9@ 7.2 ± 1.0@ 7.4 ± 1.0 7.5 ± 0.9@ 8.2 ± 1.0@
dPmax (mmHg/s) SVI 561 ± 226 560 ± 344 653 ± 404 682 ± 390 987 ± 269 674 ± 236
CI 585 ± 87 595 ± 206 579 ± 95 597 ± 137 551 ± 105 639 ± 154
SVI (stroke volume index), SVI-group; CI (cardiac index), CI-group. Data are presented as mean ± standard deviation.
∗
𝑝 < 0.05 significantly different from 𝑇bsl.#
𝑝 < 0.05 significantly different from 𝑇0.
@
𝑝 < 0.05 significantly different between groups.
Central venous oxygen saturation was in the normal
range at 𝑇bsl in both groups; then there was a significant drop
after bleeding, which normalized in the SVI-group but
remained significantly lower in the CI-group at 𝑇
4
as com-
pared to the SVI-group. The mean decrease in the CI-group
from 𝑇bsl to 𝑇4 was 15.1% and at 𝑇4 it was 8.8% lower as in the
SVI-group. Central venous to arterial CO
2
-gap was normal at
𝑇bsl in both groups. After bleeding it increased significantly
and returned to normal in the SVI-group. In the CI-groups
levels also decreased but remained elevated, although they
did not reach statistical significance.
Lactate levels were slightly elevated at 𝑇bsl in both groups,
with significant increase in the SVI-group, which reduced by
𝑇
4
. In theCI-group significant changes could not be observed,
and there was no significant difference between the groups
either.
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Table 3: Blood gas parameters during hemorrhage and fluid resuscitation.
Group 𝑇bsl 𝑇0 𝑇1 𝑇2 𝑇3 𝑇4
Oxygen delivery index (mL/min/m2) SVI 417 ± 64 250 ± 100
∗ 275 ± 71∗ 291 ± 55∗ 318 ± 55∗ 337 ± 81#
CI 410 ± 54 271 ± 62∗ 297 ± 85∗ 282 ± 47∗ 278 ± 52∗ 311 ± 61∗
Oxygen consumption (index mL/min/m2) SVI 82 ± 27 118 ± 63
∗ 111 ± 19 102 ± 24 98 ± 24 94 ± 23
CI 71 ± 43 115 ± 48∗ 111 ± 29 108 ± 21 103 ± 18 99 ± 13
Oxygen extraction (VO
2
/DO
2
) SVI 0.20 ± 0.06 0.40 ± 0.11
∗ 0.36 ± 0.06∗ 0.33 ± 0.11∗ 0.29 ± 0.09∗# 0.27 ± 0.13#
CI 0.17 ± 0.09 0.40 ± 0.18∗ 0.38 ± 0.09∗ 0.36 ± 0.08∗ 0.34 ± 0.14∗ 0.33 ± 0.11∗
Arterial pH SVI 7.48 ± 0.04 7.46 ± 0.07 7.44 ± 0.06 7.41 ± 0.11 7.45 ± 0.04 7.46 ± 0.04
CI 7.44 ± 0.04 7.43 ± 0.06 7.42 ± 0.05 7.47 ± 0.03 7.42 ± 0.05 7.45 ± 0.05
Partial pressure of oxygen in arterial blood (mmHg) SVI 94.5 ± 26.5 94.9 ± 27.8 90.1 ± 20.2 94.9 ± 27.1 93.1 ± 27.1 95.5 ± 30.1
CI 88.3 ± 28.8 89.8 ± 28.8 97.6 ± 30.2 89.2 ± 22.5 93.8 ± 32.6 88.2 ± 27.6
Arterial oxygen saturation (%) SVI 97.3 ± 1.5 96.7 ± 2.1 96.3 ± 2.0 97.0 ± 1.5 97.0 ± 1.7 96.9 ± 1.8
CI 95.4 ± 3.6 95.3 ± 5.0 96.1 ± 4.2 98.6 ± 1.5 95.6 ± 4.8 96.0 ± 3.2
Central venous oxygen saturation (%) SVI 77.4 ± 6.6 57.5 ± 10.8
∗ 60.9 ± 4.8∗ 64.3 ± 9.2∗ 68.4 ± 8.6∗# 72.9 ± 7.5
CI 79.2 ± 8.1 56.7 ± 17.0∗ 58.5 ± 10.6 59.7 ± 8.0 63.0 ± 14.7 64.1 ± 11.6#@
Venous to arterial carbon dioxide gap (mmHg) SVI 5.7 ± 2.4 10.1 ± 2.6
∗ 8.9 ± 1.7 7.5 ± 2.4 7.2 ± 2.7 5.3 ± 2.3#
CI 4.0 ± 3.1 9.9 ± 6.0∗ 8.8 ± 2.4∗ 8.5 ± 3.0 8.1 ± 3.1 7.6 ± 4.3
Lactate (mmol/L) SVI 2.54 ± 1.01 3.97 ± 1.80
∗ 4.72 ± 2.29∗ 4.37 ± 2.37∗ 3.90 ± 2.25∗ 3.26 ± 1.95
CI 3.32 ± 1.26 4.49 ± 1.83 4.50 ± 2.40 4.32 ± 0.69 4.05 ± 2.52 3.77 ± 2.32
Hemoglobin (g/dL) SVI 11.6 ± 1.5 10.7 ± 1.5 10.4 ± 1.46
∗ 9.4 ± 1.2∗# 8.3 ± 1.5∗# 8.1 ± 0.9∗#
CI 11.2 ± 0.7 10.4 ± 1.2 9.5 ± 1.2∗ 9.2 ± 0.9∗# 8.4 ± 0.6∗# 8.2 ± 1.5∗#
SVI (stroke volume index), SVI-group; CI (cardiac index), CI-group. Data are presented as mean ± standard deviation.
∗
𝑝 < 0.05 significantly different from 𝑇bsl.#
𝑝 < 0.05 significantly different from 𝑇0.
@
𝑝 < 0.05 significantly different between groups.
4. Discussion
In this studyCI-based resuscitation resulted in residual hypo-
volemia compared to SVI-based fluid management as indi-
cated by both macro-hemodynamic indices and measures of
oxygen debt in a bleeding-resuscitation animal experiment.
4.1. Fluid Resuscitation. Fluid therapy is often regarded as the
first line of support in most shock states and this holds espe-
cially true for acute bleeding. Fluid infusions directly increase
intravascular volume and subsequently improve global and
regional perfusion and oxygen delivery. However, this benefit
can only occur in patients who are on the ascending limb
of the Frank-Starling curve. In patients, who are regarded
hypovolemic, only 50% respond to fluid, as defined by a 10–
15% increase in stroke volume [11]. Although fluid resusci-
tation is a potentially lifesaving intervention large volumes
can result in severe tissue edema and clinical signs of volume
overload. These effects are mainly articulated in encapsu-
lated organs, which have limited capacity to accommodate
additional volume without compromising tissue perfusion.
There is mounting evidence that both hypovolemia and
fluid overload are associated with impaired organ function
and increased risk of dying [2, 12, 13]. Therefore, adequate
monitoring and defining appropriate resuscitation end points
are of pivotal importance. However, according to recent
large international surveys physicians apply monitoring and
indicate fluid therapy based mainly on parameters, which are
unable to predict fluid responsiveness. Several studies showed
thatmean arterial pressure and staticmarkers of preload such
as CVP, pulmonary capillary occlusion pressure have limited
value in guiding fluid management; however more than 80%
of physicians working in anesthesiology or in critical care
still rely mainly on these parameters [14, 15]. Over the last 20
years there were 21 clinical trials published on perioperative
goal-directed therapy [16]. In these studies hemodynamic
goals showed a great variability. The most frequently used
parameters to guide fluid management were CI, SV, SVV,
PPV, CVP, MAP, echo-derived dynamic indices, pulmonary
artery occlusion pressure, DO
2
, and oxygen extraction ratio.
This clearly shows that universally accepted hemodynamic
target by which fluid therapy should be tailored is missing.
It is important to note that recent milestones of multi-
center clinical trials on fluid therapy [17–20] “neglected”
this approach to some extent, and in these studies fluid
administrationwasmainly based on the clinicians’ “intuition”
or inadequate indices rather than appropriate hemodynamic
parameters of intravascular blood volume. Nevertheless, one
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of the most important messages of these large trials, which is
also in accord with the results of recent surveys [14, 15], is that
our everyday routine practice should be revised and may be
harmful.
The physiological rationale of intravenous fluid admin-
istration to a patient is to increase SV, hence DO
2
, and also
perfusion. In several studies CI was applied as therapeutic
goal [21–24], although CO is the product of heart rate and SV;
therefore compensatory mechanisms, such as tachycardia,
may compensate residual hypovolemia. In the current exper-
iment we found major differences between the SVI- and CI-
guided groups. The latter received significantly less fluid in
total and also required less fluid to replace every unit of lost
blood. These results suggest that simply applying invasive
hemodynamics as compared to our daily routine monitoring
may not be sufficient, and depending on the parameter we
chose to follow, subjects can still remain under- or overresus-
citated.
4.2. SVI- versus CI-Guided Goal-Directed Resuscitation: Hemo-
dynamics. During bleeding to restore homeostasis, the sym-
pathetic nervous system becomes activated and releases epi-
nephrine and norepinephrine. As a result, venous return will
increase, while on the arterial side norepinephrine-caused
vasoconstriction tries to maintain perfusion. Because of this
sympathetic activation, heart rate and myocardial contractil-
ity will also increase. During resuscitation, our pivotal goal
is to restore circulating blood volume by increasing SV to
improve oxygen delivery. Recent clinical investigations [25,
26] showed positive effects of SV optimization, and there is
frank evidence that PPV and SVV are well-established indi-
cators of fluid responsiveness in mechanically ventilated sub-
jects without cardiac arrhythmias [27]. Therefore in our exper-
iment, SVV was the primary outcome variable as the closest
to predict fluid responsiveness, hence hypovolemia. In both
groups there was a significant increase after bleeding but
values returned to baseline only in the SVI-group. In the CI-
group neither dynamic (SVV/PPV) nor static indicators of
preload (GEDI) normalized to their baseline values, indicat-
ing, that it was not the circulating blood volume, but heart
rate compensated CO, which normalized, leaving residual
hypovolemia unnoticed.
It is interesting to note that CVP changed to a lesser
degree than any other hemodynamic parameter; hence our
results provide further evidence of the limitations to CVP
as a goal during fluid resuscitation, also described by others
[7]. Although mean arterial pressure followed hemodynamic
changes to some extent, there was no difference between the
groups, indicating that for fine tuning hemodynamics, just as
CVP, MAP also has limited value. This is due to the fact that
MAP and CI do not correlate with each other [28].
However, “normalizing” global hemodynamics is one
thing, but normalizing the balance between oxygen delivery
and consumption is another. Therefore, once the macro-
hemodynamic parameters look physiological, their effect on
DO
2
/VO
2
should also be assessed.
4.3. SVI- versus CI-Guided Goal-Directed Resuscitation: Oxy-
gen Debt. As it has already been mentioned the primary
goal of fluid resuscitation in hypovolemia is to maintain
adequate oxygen delivery to the tissues. During bleeding,
when oxygen demand/consumption is unchanged (in anes-
thetized subjects) or increased (in awake subjects), impaired
oxygen delivery has to be accompanied by increased oxygen
extraction ratio, which can be detected in the changes of
ScvO2. Physiological mixed venous oxygen saturation ranges
between 68% and 77%, and ScvO2 is considered to be 5%
higher [29]. Indeed, in patients under general anesthesia the
ScvO2 is often higher than 80%, which is due to the reduced
oxygen demand and consumption; hence, higher values
should be considered as “normal” [30, 31]. Furthermore, in
our previous experiments, ScvO2 showed good correlation
with oxygen extraction [32, 33]. Therefore, as interpretation
of absolute values may prove difficult in different conditions
evaluation of the changes of ScvO2 may be more helpful. In
the current experiment we found that ScvO2 improved but
remained significantly lower at the end of the experiment
as compared to baseline values in both groups. This is most
likely due to hemodilution, a feature also found in our
previous study [9]. However, in the CI-group ScvO2 remained
15% lower as compared to baseline and more than 10% lower
as in the SVI-group, indicating severe oxygen debt. Although
interpreting ScvO2 may be difficult when there is problem
with extraction typically seen in sepsis, there is international
consensus that low levels should be an important warning
sign to indicate inadequate DO
2
to meet oxygen demands
[34]. In our experiment in the CI-group, we measured lower
DO
2
, ScvO2 and higher oxygen extraction ratio, indicating
that animals resuscitated for CI remained in oxygen debt.
Several authors have reported increased dCO
2
in different
low flow states [35–38]. In hypoxemia caused anaerobic
metabolism, hydrogen ions are generated by the hydrolysis
of adenosine triphosphate to adenosine diphosphate, and by
the increased production of lactic acid [36]. These hydrogen
ions are buffered by bicarbonate present in the cells, and
this process will generate CO
2
production [37]. Arterial
PaCO
2
is dependent on pulmonary gas exchange, and central
venous PvCO
2
is dependent on the capability of blood
flow to wash out carbon dioxide from the tissues. The Fick
principle adapted to carbon dioxide demonstrates the inverse
relationship between CO and dCO
2
[39]. Thus, it has been
postulated that increased dCO
2
reflects decreased flow. In the
current experiment dCO
2
followed the same pattern, what
we observed previously, and returned to the baseline value at
the end of resuscitation in the SVI-group. In the CI-group, it
remained elevated, above the physiological value of 6mmHg,
but this difference did not reach statistical significance.
Nevertheless, this tendency gives further evidence that these
animals were underresuscitated.
Lactate, the product of anaerobic metabolism, is often
referred to as one of the main biochemical targets to be
treated during resuscitation [40]. In our experiment, levels
were slightly elevated at baseline, possibly due to the relatively
long set-up time of the experiment, and there was an increase
and then decrease during interventions, but these changes
were not as dramatic as one may expect. However, it is
important to note, that this experimental model is similar to
a “moderate” bleeding event, and animals were resuscitated
BioMed Research International 7
within a relatively short period of time.Due to the physiologic
relationship between DO
2
and VO
2
, namely, due to compen-
satory mechanisms when there is a drop in DO
2
, up to a
certain pointVO
2
remains stable, in otherwords independent
fromDO
2
.Therefore, although theVO
2
/DO
2
ratio is increas-
ing, but it does not cause and mean cellular hypoxia, hence
aerobic metabolism is not disturbed. To conclude, animals
during this experiment were heading towards shock; they
were in oxygen debt but remained on the flat part of the
VO
2
/DO
2
curve, not reaching cellular hypoxia and shock,
meaning the steep part of the curve.This is also supported by
the arterial pH, which remained normal throughout in both
groups. In general, this is the rationale and advantage of mea-
suring ScvO2, and for similar reasons SVV or PPV, because
we are “one step ahead” of cellular hypoxia and circulatory
shock.
4.4. Limitations. One of the limitations of this experiment
is that we could not provide data on microcirculation and
regional blood flow, which would be interesting to see.
Furthermore, these results can only partially be extrapolated
for the real clinical settings. Reducing the SVI by 50% is a
strictly controlled scenario, rarely happening in the everyday
practice.The observation period at the end of the experiment
was also short; therefore, long-term effects of SVI or CI-based
fluid resuscitation could not be assessed. Another limitation
of themodel is that bleedingwas relatively fast, causing a sym-
pathetic burst, which is a reality in trauma and when major
bleeding occurs on the wards, but in the operating room
intravascular volume loss and bleeding caused hypovolemia
usually occurs over a longer period of time.
5. Conclusion
In this experiment we have shown that SVI-based goal-
directed resuscitation of a bleeding subject seems superior
to CI-guided resuscitation as indicated by both hemody-
namic parameters and measures of oxygen debt returning
to baseline in the SVI-group, which was incomplete in the
CI-group. However, we would like to emphasize that treating
one single parameter during resuscitation is not warranted. It
is not one single parameter, but the “hemodynamic puzzle”
what we have to solve [41]. Therefore, it is necessary to
put hemodynamic variables and measures of VO
2
/DO
2
into
context in a way that once macro-hemodynamic parameters
are “normalized,” adequacy of treatment has to be checked
by measures of oxygen debt. Measuring SVV or PPV and
simple blood gas driven variables such as ScvO2 and dCO2
are valuable tools to solve this puzzle as quickly as possible.
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